1Rotterdam ESHREASRM- Sponsored PCOS Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J]. Fertil. Steril,2004,81 (1) : 19-25
3Seli E, Duleba AJ. Should patients with polycystic ovarian syndrome be treated with metformin[J]. Hun Reporod, 2002,17 (9) :2230-2236.
二级参考文献5
1Rotterdam ESHRE/ASRM-Sponsored PC0S Consensus Workshop Group.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Fertil Steril,2004,81(1):19 -25.
2Moghtti P,Castello R,Negri C,et al.Metfonnin effects on clinical features,endocrine and metabolic profiles,and insulin sensitivity in polycystic ovary syndrome:a randomized,double-blind,placebo-controlled 6-month trial,followed by open,long-term clinical evaluation[J].J Clin Endocrinol Metab,2000,85(1):139-146.
3Hahn S,Quadbeck B,Elsenbruch S,et al.Metfonnin,an efficacious drug in the treatment of polycystic ovarysyndrome[J].Dtsch Med Wochenschr,2004,129(19):1059-1064.
4Kriplani A,Agarwal N.Effects of metformin on clinical and biochemical parameters in polycystic ovary syndrome[J].J Reprod Med,2004,49(5):361-367.
